LDHA and mesothelioma: Furthermore, we used innovative in vitro and in vivo models to characterise the anti-proliferative capacity of LDH-A inhibitors, in order to provide mechanistic insights regarding the aggressive behaviour of mesothelioma, and in an attempt to contribute to the rational development of new prognostic and therapeutic approaches.